Articles tagged with Asymmetric Synthesis
Researchers developed a palladium-catalyzed tandem cyclization strategy to construct chiral bridged oxazole bicyclic skeletons with high diastereoselectivity and enantioselectivity. The method exhibits excellent substrate universality, providing an efficient route for synthesizing complex three-dimensional structures.
Scientists at The University of Osaka have developed an innovative method for producing NOBIN, a valuable molecule used in pharmaceuticals, by combining a vanadium catalyst and LED light. This clean process yields only water as a byproduct, showcasing exceptional environmental compatibility and waste reduction.
A novel mixed-ligand strategy creates ultrahigh surface area, chemically stable chiral MOFs ideal for practical applications in asymmetric catalysis. The frameworks demonstrate record-breaking surface areas and exceptional structural features, making them suitable as heterogeneous catalysts.
A research team has developed a simplified synthesis method for organic fluorophores using formaldehyde, reducing molecular size and increasing atomic efficiency. The new technique can also be applied to in vivo environments, showing promise for life sciences research and diagnostics applications.
A new synthesis method, template synthesis, enables the creation of multilayered perovskites with unique ferroelectric properties. The number of layers affects the material's behavior, switching between conventional and indirect ferroelectricity models.
Researchers at Tokyo Institute of Technology developed a new strategy to synthesize 3D π-extended carbohelicenes, overcoming molecular distortions and achieving CPL brightness of up to 513 M–1 cm–1. The study provides a solid groundwork for further research and development of high-performance carbohelicenes.
Researchers at USTC developed novel chiral boryl radical catalysts for asymmetric catalysis, achieving high reaction efficiency and selectivity. The catalysts exhibit exceptional capabilities in constructing chiral functional molecules through a precision-controlled catalytic cycle.
Researchers successfully developed a novel method for transforming atropisomers into specific enantiomers using the Pauson–Khand reaction. The reaction achieved high enantiomeric excesses and selectivity, opening up new avenues for synthesizing pharmaceutical compounds.
Researchers have made a significant advancement in the synthesis of β-lactam scaffolds, structural components frequently found in essential antibiotics. The breakthrough uses nickel catalysts to overcome challenges in β-lactam synthesis, enabling more efficient and simplified production of high-value materials.
Researchers at Tokyo University of Science successfully synthesized tanzawaic acid B in large amounts, paving the way for new antibiotic development. The breakthrough method could lead to creation of various compounds for pharmaceuticals, including new antibiotic candidates.
Researchers at Texas Tech University and Nanjing University have developed a new method for controlling chirality in asymmetric catalysis using chiral aggregates. This method, called aggregation-induced catalysis (AIC), uses the aggregation of chiral auxiliary raw materials or catalysts to achieve controlled chirality in reactions. The...
Researchers successfully synthesized isotopic atropisomers based on carbon isotope discrimination, exhibiting high rotational stability and stereochemical purity. The findings hold promise for fundamental understanding of isotopic atropisomers with implications in organic and medicinal chemistry.
A team of Japanese researchers has successfully developed a recycling photoreactor that enables the synthesis of optically pure compounds with high yields, achieving an optical purity of 98-99%. The system uses a two-step rapid photoracemization process and can produce enantiomerically pure chiral sulfoxides in yields higher than 80%.
Researchers have developed a novel catalytic approach to synthesize monocyclic 3-(pyrrol-1-yl)-azetidin-2-ones, which show potential as therapeutic agents. The method yields all four diastereomers with high selectivity and has been published in Current Organocatalysis.
Chemists at the University of Groningen have developed a simple one-pot reaction to produce chiral Z-alkenes, previously inaccessible molecules. This method uses a phosphine molecule as a starting point, reducing the need for purification and allowing for the creation of complex functionalised alkenes.
Researchers at USTC developed a new strategy for synthesizing axially chiral allenic compounds, achieving high enantiopurity and stereoselectivity. The method involves nickel-catalyzed asymmetric propargyl substitution and Myers rearrangement reactions.
Researchers at NTU Singapore have developed a new method to generate sulphur pharmacophores, which are crucial for drug discovery. The method uses a catalyst called pentanidium and can produce multiple variations of pharmacophores, making the process more efficient and fruitful.
Researchers from Shibaura Institute of Technology synthesized atropisomeric N-aryl quinazoline-4-thiones, showing unprecedented isotopic atropisomerism due to rotational restriction around an N-Ar bond. The findings support the formation of diastereomers and have potential applications in pharmaceuticals.
A team of scientists has developed an iridium-catalyzed hydrogen addition method to control asymmetry in drug synthesis. This approach reduces wasteful by-products and enables targeted synthesis with high precision.
A team led by Dr. Shoufeng Lan is investigating the use of electromagnetic control over the synthesis of chiral compounds at an atomic level, which could lead to safer and cheaper pharmaceuticals. The researchers hope to create chiral seeds at the atomic scale and transfer chirality using cutting-edge technologies.
Researchers at Hong Kong University of Science and Technology have developed a novel approach to synthesize chiral tetraarylmethanes, a type of spherical molecule. The new method enables efficient access to this previously underexplored chemical space, with promising activity against cancer cells and enterovirus.
Researchers at USTC developed a mild and general nickel-catalysed asymmetric reductive hydroalkylation to synthesise chiral aliphatic amines. They achieved this by replacing equivalent metal reagents with olefins, facilitating carbon-carbon coupling under mild conditions.
Researchers have developed a method to synthesize N-C axially chiral compounds, which have promising applications in medicine and agriculture. The team's breakthrough enables the creation of highly enantioselective syntheses using chiral catalysts, leading to potentially useful compounds with therapeutic properties.
Scientists at Nagoya Institute of Technology have developed a new method for synthesizing chiral N,N-acetals, which are crucial components in diuretic drugs and other bioactive compounds. The method uses diketones as starting materials and produces high enantiopurity with yields up to 99%.
Researchers have developed a novel approach for chiral drug synthesis in living systems, utilizing neutrophil-directed asymmetric transfer hydrogenation. This method enables site-selective synthesis of enantiomers, which is crucial for controlling the pharmacological activity of chiral drugs like Ibuprofen.
ICIQ researchers have developed a new radical route for synthesizing chiral molecules, combining enantioselective iminium ion chemistry and photoredox catalysis under mild conditions. This breakthrough could lead to more sustainable and responsible stereoselective chemistry.
Researchers at Toyohashi Tech have successfully demonstrated the enantioselective phenoxylation of β-keto esters, allowing for the synthesis of α-aryloxy-β-keto esters with high enantioselectivity. This method enables the creation of biologically active compounds for potential treatment of type 2 diabetes.
A Duke University chemist has created a method to produce synthetic ketone molecules in only one shape, using a faster and more efficient process than previous methods. This breakthrough could lead to the development of drugs with fewer side effects and increased patient safety.
Researchers at UIC successfully synthesized the rare molecule laulimalide, a potent anticancer compound with potential to surpass existing cancer drug Taxol. The stepwise synthesis allows for control of stereochemistry, enabling testing of variants with enhanced antitumor activity.